207 related articles for article (PubMed ID: 4226616)
1. Delayed contact sensitivity to catechols. 3. The relationship of side-chain length to sensitizing potency of catechols chemically related to the active principles of poison ivy.
Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
J Immunol; 1967 Aug; 99(2):370-5. PubMed ID: 4226616
[No Abstract] [Full Text] [Related]
2. Delayed contact sensitivity to catechols. II. Cutaneous toxicity of catechols chemically related to the active principles of poison ivy.
Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
J Immunol; 1967 Aug; 99(2):365-9. PubMed ID: 4226615
[No Abstract] [Full Text] [Related]
3. Poison oak hyposensitization. Evaluation of purified urushiol.
Epstein WL; Baer H; Dawson CR; Khurana RG
Arch Dermatol; 1974 Mar; 109(3):356-60. PubMed ID: 4273614
[No Abstract] [Full Text] [Related]
4. Absorption through the skin of sensitizing and nonsensitizing substances related to the active principle of poison ivy.
Baer H; Godfrey H
Adv Biol Skin; 1971; 11():161-5. PubMed ID: 4124136
[No Abstract] [Full Text] [Related]
5. Synthesis of compounds structurally related to poison ivy urushiol. 3. 3-n-Pentadecylcatechol and 3-n-alkylcatechols of varying side-chain length.
Kurtz AP; Dawson CR
J Med Chem; 1971 Aug; 14(8):729-32. PubMed ID: 4107134
[No Abstract] [Full Text] [Related]
6. Occupational poison ivy and oak dermatitis.
Epstein WL
Dermatol Clin; 1994 Jul; 12(3):511-6. PubMed ID: 7923948
[TBL] [Abstract][Full Text] [Related]
7. The synthesis of compounds structurally related to poison ivy Urushiol. 4,5-dimethyl-3-pentadecylcatechol.
Byck JS; Dawson CR
J Org Chem; 1967 Apr; 32(4):1084-8. PubMed ID: 4227456
[No Abstract] [Full Text] [Related]
8. [Rhus dermatitis or poison ivy dermatitis in Lorraine].
Beurey J; Mougeolle JM; Weber M; Mazet J
Ann Dermatol Venereol; 1980; 107(1-2):65-7. PubMed ID: 6445173
[No Abstract] [Full Text] [Related]
9. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed.
Long D; Ballentine NH; Marks JG
Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283
[TBL] [Abstract][Full Text] [Related]
10. Single dose parenteral hyposensitization to poison ivy urushiol in guinea pigs.
Walker LA; Watson ES; elSohly MA
Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):565-76. PubMed ID: 8576546
[TBL] [Abstract][Full Text] [Related]
11. Perfluorinated analogues of poison ivy allergens. Synthesis and skin tolerogenic activity in mice.
Fraginals R; Schaeffer M; Stampf JL; Benezra C
J Med Chem; 1991 Mar; 34(3):1024-7. PubMed ID: 1825847
[TBL] [Abstract][Full Text] [Related]
12. Saturated analogues of poison ivy allergens. Synthesis of trans,trans- and cis,trans-3-alkyl-1,2-cyclohexanediols and sensitizing properties in allergic contact dermatitis.
Lepoittevin JP; Benezra C
J Med Chem; 1986 Feb; 29(2):287-91. PubMed ID: 2936885
[TBL] [Abstract][Full Text] [Related]
13. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
[TBL] [Abstract][Full Text] [Related]
14. Poison ivy/oak dermatitis. Part I: Prevention--soap and water, topical barriers, hyposensitization.
Fisher AA
Cutis; 1996 Jun; 57(6):384-6. PubMed ID: 8804839
[No Abstract] [Full Text] [Related]
15. Synthesis of compounds structurally related to poison ivy urushiol. 4. 3-(1-Alkyl)alkylcatechols of varying side-chain shape and flexibility.
Kurtz AP; Dawson CR
J Med Chem; 1971 Aug; 14(8):733-7. PubMed ID: 4107135
[No Abstract] [Full Text] [Related]
16. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens.
Smith KJ; Skelton HG; Nelson A; Wagner KF; Hackley BE
Dermatology; 1997; 195(2):145-9. PubMed ID: 9310722
[TBL] [Abstract][Full Text] [Related]
17. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
Dupuis G
Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
[TBL] [Abstract][Full Text] [Related]
18. Patch testing versus history in poison ivy/oak dermatitis.
Zhai H; Chang YC; Singh M; Maibach HI
Contact Dermatitis; 1997 Apr; 36(4):226. PubMed ID: 9165209
[No Abstract] [Full Text] [Related]
19. Allergic contact dermatitis caused by Lithraea molleoides and Lithraea brasiliensis: identification and characterization of the responsible allergens.
Alé SI; Ferreira F; González G; Epstein W
Am J Contact Dermat; 1997 Sep; 8(3):144-9. PubMed ID: 9249282
[TBL] [Abstract][Full Text] [Related]
20. COMPARISON OF THE POTENCY OF POISON IVY EXTRACTS WITH SYNTHETIC PENTADECYLCATECHOL IN SENSITIVE HUMANS.
AUERBACH R; BAER H
J Allergy; 1964; 35():201-5. PubMed ID: 14160428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
